Acrivon Therapeutics, Inc. (ACRV) Stock Profile — Insider Trades & Financials

Net Income-$19.0M

EPS$-1.53

Market Cap$57.0M

Price Performance

Historical data including institutional events

Loading price data...

Company Profile

Peter Blume-Jensen

CEO & Executive Director

Company profile for Acrivon Therapeutics, Inc. (ACRV) stock, with a description, list of executives, contact details and other key facts.

Founded: 2018
Employees: 1
Headquarters: WATERTOWN, MA, United States
Website: acrivon.com

Peer ComparisonRevenue ($B)

▾

⚡

Core Efficiency

ROE?

-16.87%

ROA?

-14.64%

D/E Ratio?

0.15

📊

Profitability Ratios

Current Ratio?

7.69

Loading comparison...

Earnings Calendar

Filing history and next expected filing date

Next Expected Filing

Sep 2, 2026 (in 148 days)

Annual Report (10-K) — Based on filing pattern

Sep 2, 2026

Predicted10-K

Mar 19, 2026

10-KQ4 20253d after period end

Mar 19, 2026

10-KFY 202578d after period end

Nov 13, 2025

10-QQ3 20256d after period end

Aug 13, 2025

10-QQ2 20255d after period end

May 14, 2025

10-QQ1 20255d after period end

Mar 27, 2025

10-KQ4 20243d after period end

Nov 13, 2024

10-QQ3 20246d after period end

Aug 13, 2024

10-QQ2 20245d after period end

Loading company sections...

Acrivon Therapeutics, Inc.

Price Performance

Company Profile

Core Efficiency

Profitability Ratios

Earnings Calendar

Core Efficiency

Profitability Ratios

Earnings Calendar

Data Freshness